Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in...

Area of Science:

• Endocrinology
• Molecular Biology
• Gerontology

Background:

• Intracrinology involves local sex steroid synthesis and activation in tissues, independent of circulating hormone levels.
• Aging leads to declining androgens, causing hormone imbalances and symptoms like muscle loss and low libido.
• Conventional testosterone replacement therapy (TRT) focuses on serum levels, neglecting crucial local intracrine production.

Purpose of the Study:

• To review the role of intracrinology in aging and hormone imbalances.
• To explore tissue-specific effects of testosterone, dihydrotestosterone (DHT), and estradiol (E2).
• To discuss strategies for managing conversion imbalances and limitations of serum monitoring.

Main Methods:

• Narrative review of scientific literature on intracrinology and hormone replacement.
• Exploration of steroidogenic enzyme roles and tissue-specific hormone effects.
• Analysis of continuous-release subcutaneous testosterone pellet therapy and its impact on intracrine function.

Main Results:

• Peripheral tissues produce most bioactive testosterone, DHT, and E2 locally from precursors.
• Continuous testosterone pellets provide a stable substrate for on-demand tissue hormone production.
• An enzyme-aware, symptom-driven model prioritizes clinical relief and individual profiles over serum targets.

Conclusions:

• Intracrine hormone production is critical for managing age-related hormone imbalances and symptoms.
• Continuous-release testosterone pellets offer a promising approach for individualized hormone optimization.
• Further randomized controlled trials are needed to validate this symptom-driven, intracrine-focused model.